Dry Shampoo Market Companies

Why the Dry Shampoo Market Is Expanding?

The Dry Shampoo Market is accelerating on the back of shifting hair-care habits and tightening formulation regulation. Per MRFR analysis, the market was valued at USD 3.14 Billion in 2025 and is projected to reach USD 5.98 Billion by 2035, registering a CAGR of 6.38% across the 2026–2035 forecast window. Spray aerosols command roughly 69.9% of category volume in 2025, reflecting entrenched consumer preference for quick-application volumizing formats, while Powder is the fastest-growing product type at a 7.17% CAGR as propellant-free, VOC-compliant formulations gain share. By nature, Conventional formulations still account for approximately USD 2.42 Billion of 2025 revenue, while Organic variants are expanding fastest at a 7.48% CAGR. Europe leads regionally with roughly 37.8% of global revenue in 2025, followed by North America at approximately 31.0%; Asia-Pacific is the standout growth region at a 7.24% CAGR, driven by urbanization in India and China.

Regulatory pressure is a demand driver that is structural in nature, rather than cyclical. The EU's Cosmetics Regulation 1223/2009 imposes parallel constraints that are compelling manufacturers to adopt compressed-gas propellants and powder-based delivery, while California's Air Resources Board limits VOC content in hair-care aerosols at 55% by weight, with a proposed reduction to 50% by 2028. In November 2023, the FDA published final facility-registration guidance for the Modernization of Cosmetics Regulation Act (MoCRA) in the United States. This legislation has resulted in an estimated USD 120 million in incremental industry-wide testing costs, thereby raising the compliance bar and consolidating share among complying incumbents while simultaneously putting pressure on unbranded imports. On top of this, the time between category-defining moments and purchase is being compressed by accelerated urban lifestyles (global urbanization exceeded 57% in 2024) and social-commerce discovery (dry-shampoo hashtags garnered over 4.2 billion TikTok and Instagram views in 2024).

Why These Companies Are Leading?

Category leadership in dry shampoo increasingly separates into three distinct plays: single-brand concentration, diversified group portfolios, and indie/PE-backed specialization. Church & Dwight has effectively made a single-SKU-family bet, naming Batiste its “#1 Dry Shampoo” brand in its own FY2025 Annual Report and capturing an estimated 12–16% of category revenue as a result. Unilever, P&G, Henkel, and L'Oréal instead spread exposure across multiple owned brands (Dove/TRESemmé, Herbal Essences/Pantene, Schwarzkopf/got2b, Klorane) inside much larger consumer-goods groups, using scale and R&D budgets measured in the hundreds of millions to defend share incrementally rather than dominate outright. A third track has emerged in private hands: amika, majority-owned by Bansk Group since 2022, claims the #1 prestige dry-shampoo position in the US by 2024 Circana dollar sales — proof that category leadership no longer requires Big Beauty's balance sheet.

Top 10 Global Dry Shampoo Companies — MRFR Rankings (2026)

All revenue figures are validated from official company annual reports, investor relations disclosures, or SEC filings. Where official figures are unavailable for private companies, this is explicitly noted.

*Private company revenues marked 'Undisclosed' where no official published financials are available. Where a brand is owned by, or consolidated within, a larger public group, group- or segment-level revenue is cited as validated context, consistent with MRFR sourcing rules.

Detailed Company Profiles

1. Church & Dwight Co., Inc. | NYSE: CHD | Ewing, New Jersey, USA

Batiste is explicitly identified as the company's "#1 Dry Shampoo" brand in its own FY2025 Annual Report, making it one of only seven "Power Brands" that carry the entire USD 6.2 Billion enterprise. Church & Dwight's dry-shampoo strategy is a concentration bet, not a portfolio hedge. This dependence on a single brand has a dual impact: it provides Church & Dwight with a significant category share (approximately 12–16%) without the R&D burden of a diversified portfolio. However, it also means that any setbacks at Batiste have a direct impact on the group's results.

2. Unilever PLC | NYSE: UL / LSE: ULVR | London, United Kingdom

Unilever enters the dry shampoo market from the top down: Dove and TRESemmé are part of a EUR 12.8 billion Beauty & Wellbeing segment that management is intentionally expanding as a proportion of the post-Ice-Cream-demerger group. Unilever is positioning dry shampoo as biotechnology-adjacent rather than purely cosmetic, a position that is supported by EUR 836 Million in FY2025 R&D spend and a stated ambition to transform scalp-care into a full "scalp-wellness platform." The prediction is that microbiome-balancing actives will emerge as the next significant differentiator in the category, rather than yet another fragrance variant.

3. Procter & Gamble Company | NYSE: PG | Cincinnati, Ohio, USA

P&G's USD 84.3 Billion FY2025 net sales make it the largest company touching this market, yet dry shampoo sits inside a Beauty segment that declined low single digits even as the broader company grew organically. Herbal Essences and Pantene's Bio: Renew dry shampoo line functions as a defensive share-protection play rather than a growth spearhead — leaning on P&G's retail-partnership depth and travel-size distribution rather than category-specific innovation spend.

4. Henkel AG & Co. KGaA | ETR: HEN3 | Düsseldorf, Germany

Henkel is buying its way into faster hair-care growth rather than building it internally: the company's March 2026 agreement to acquire “Not Your Mother's” — a North American styling brand generating roughly EUR 190 Million in FY2025 sales with double-digit growth — sits alongside Schwarzkopf and got2b's existing dual professional-salon/mass-retail channel strategy. With FY2025 group sales of EUR 20.5 Billion, the acquisition signals that Henkel views bolt-on M&A, not R&D reallocation, as the faster route to defending its EU-anchored hair-care position against faster-growing US indie brands.

5. L'Oréal S.A. | EPA: OR | Clichy, France

L'Oréal's Klorane botanical powder line benefits from a company-wide tailwind: haircare was the Group's number-one growth contributor in FY2025, advancing 12.9% as L'Oréal's EUR 44.05 Billion in sales grew on the back of a EUR 1.37 Billion R&I budget (3.1% of sales). The June 2025 acquisition of prestige styling brand Color Wow extends that momentum into styling-adjacent texture products bordering the dry-shampoo category.

6. Kao Corporation | TYO: 4452 | Tokyo, Japan

Kao's John Frieda dry-shampoo line is part of a broader corporate turnaround. In FY2025, net sales increased by 3.7% to JPY 1,688.6 Billion. The Cosmetics Business experienced a significant improvement in profitability as a result of Kao's structural-reform program, and the Global Consumer Care unit extended a 30-month streak of Japan market-share gains. Kao is redirecting reform-driven savings toward its highest-return consumer-care categories, rather than pursuing standalone dry-shampoo innovation. John Frieda is anticipated to align with Kao's overarching "quality over quantity" strategy rather than pursue category-specific expansion, according to MRFR.

7. Coty Inc. | NYSE: COTY | New York, New York, USA

Coty's historical link to dry shampoo ran through Clairol — but that connection is now severed. Coty completed the sale of its remaining 25.8% stake in Wella Company (owner of Clairol, OPI, ghd, and Wella) to KKR for approximately USD 750 Million in December 2025, exiting hair care entirely to refocus its USD 5.89 Billion FY2025 revenue base on prestige fragrance and color cosmetics. MRFR flags this as a genuine category departure: Coty is not a competitive dry-shampoo presence going forward, and any residual company-list association with Clairol reflects historical, not current, ownership.

8. Shiseido Company, Limited | TYO: 4911 | Tokyo, Japan

Shiseido's prestige scalp-care line operates inside a company under real financial strain: FY2025 net sales fell 2% to JPY 970.0 Billion and the group posted a net loss, even as core operating profit beat management's own target on aggressive structural reform. Geopolitical friction between China and Japan continues to weigh on Shiseido's travel-retail channel — historically a key prestige-beauty discovery point.

9. amika (Bansk Group) | Private | Brooklyn, New York, USA

amika is the category's proof-of-concept for indie-brand leadership: Bansk Group's own data cites amika as the #1 prestige dry shampoo brand in the US by 2024 Circana dollar sales, achieved without the R&D or distribution scale available to Unilever or P&G. Bansk, led by former Coty and Reckitt Benckiser CEO Bart Becht, acquired majority control in 2022 and has since layered Byoma and Eva NYC onto the same platform. MRFR reads amika as the clearest signal that clean-ingredient formulation credibility, not balance-sheet size, now drives premium dry-shampoo share gains.

10. Living Proof (Unilever) | Private / Unilever Subsidiary | Cambridge, Massachusetts, USA

Living Proof competes on a technology moat rather than portfolio breadth: its MIT-originated biotechnology platform underpins 156 global patents, and its Perfect Hair Day™ Dry Shampoo has drawn independent recognition, including a CNN Underscored ranking as a top-rated formulation. Acquired by Unilever in a 100%-stake, undisclosed-terms deal in 2017, Living Proof's revenue is consolidated within Unilever's EUR 12.8 Billion Beauty & Wellbeing segment rather than reported separately.

M&A Activity Tracker

Key verified transactions shaping the Dry Shampoo Market's competitive and ownership landscape (2022–2026):

Key Trend: M&A in the Dry Shampoo Market is bifurcating into two tracks: strategics using targeted bolt-on acquisitions to defend share (Henkel/Not Your Mother's, L'Oréal/Color Wow) while private capital consolidates ownership outside Big Beauty entirely (KKR's full Wella buyout, Bansk Group's amika platform) — Coty's complete exit is the clearest signal, yet that hair care is no longer core to every major beauty conglomerate's portfolio.

R&D Investment & Innovation Signals

Leading companies are directing capital toward biotechnology-enabled actives, propellant-free formulations, and buy-versus-build M&A rather than incremental line extensions:

• Unilever committed EUR 836 Million to R&D in FY2025 across more than 4,500 scientists, explicitly targeting microbiome-balancing and biotechnology-enabled actives to reposition dry shampoo as a scalp-wellness product rather than a convenience item.
• L'Oréal held Research & Innovation spend at 3.1% of sales (~EUR 1.37 Billion) in FY2025 and used that scale to acquire Color Wow in June 2025, buying styling-adjacent innovation rather than building it in-house within the dry-shampoo-relevant Professional Products division.
• Henkel's pending acquisition of “Not Your Mother's” (announced March 2026) is a buy-versus-build signal: rather than reallocating internal R&D toward North American styling trends, Henkel is acquiring a brand already generating double-digit growth on roughly EUR 190 Million in sales.
• Church & Dwight continues to invest behind Batiste's tinted and no-white-residue variants, directly targeting the product-residue complaint that MRFR's Restraints Impact Analysis identifies as the category's top usage barrier, particularly among dark-haired users.
• amika (Bansk Group) has converted #1 prestige-dry-shampoo unit economics into international expansion capital without matching Big Beauty R&D budgets — evidence that clean-ingredient formulation credibility is becoming a standalone competitive asset, not merely a marketing claim.
• Kao is channeling Global Consumer Care structural-reform savings toward its highest-return categories, aiming to extend the 30-consecutive-month Japan market-share streak that its FY2025 results attribute in part to the Cosmetics Business turnaround.
• Living Proof's 156-patent, MIT-originated biotechnology platform functions as Unilever's scientific-credibility anchor within Beauty & Wellbeing, supporting the segment's premiumization push without requiring separate category-specific R&D disclosure.
• Industry-wide, MoCRA's ingredient-transparency mandate and California's tightening VOC caps are redirecting R&D budgets across the category toward propellant-free, rice-starch, and tapioca-based tinted formulations engineered to solve the residue problem MRFR identifies as the market's most-cited consumer complaint.